ArticleBreast cancer (Tokyo, Japan)2026
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
Kiyo Tanaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.